Our study also indicates that loss of c-MYC increases the anti-apoptotic function of BCL2A1, and that combined inhibition of BCL2A1 and c-MYC is sufficient to induce apoptosis in DLBCL. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.